+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide



CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide



Psychological Medicine 15(2): 335-340



The monoamine metabolites 5-hydroxindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) were measured in the lumbar cerebrospinal fluid (CSF) of 27 chronic schizophrenic patients who at some time had attempted suicide, and were compared with values from 27 chronic schizophrenic patients without a history of attempted suicide. There were no significant differences between either the violent or non-violent attempters and those without a history of attempted suicide in the mean lumbar CSF concentrations of the serotonin metabolite 5-HIAA, the dopamine metabolite HVA, or the norepinephrine metabolite MHPG. Significantly more of the suicide attempters had a previous major depressive episode, had received a course of ECT, and had significantly more psychiatric admissions than those who had never attempted suicide.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039435838

Download citation: RISBibTeXText

PMID: 2410941

DOI: 10.1017/s0033291700023618


Related references

Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatrica Scandinavica 81(1): 58-61, 1990

Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication. Zhonghua Shen Jing Jing Shen Ke Za Zhi 17(5): 273-277, 1984

Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Biological Psychiatry 14(3): 509-523, 1979

Characteristics of schizophrenic patients with a history of suicide attempt. International Journal of Psychiatry in Clinical Practice 8(4): 227-234, 2004

CSF monoamine metabolites in schizophrenic patients. Acta Psychiatrica Scandinavica 66(5): 350-360, 1982

Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death. Archives of General Psychiatry 43(6): 594-600, 1986

Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology 99(3): 322-327, 1989

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients. Acta Psychiatrica Scandinavica 74(3): 292-301, 1986

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research 9(4): 301-308, 1983

Decreased spinal fluid monoamine metabolites and norepinephrine in schizophrenic patients with brain atrophy. Beckmann, H And P Riederer (Ed ) Pathochemical Markers in Major Psychoses; Symposium, Vienna, Austria, July 1983 X+158p Springer-Verlag: New York, N Y , Usa; Berlin, West Germany Illus 88-95, 1985

CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites. Psychiatry Research 19(2): 93, 1986

Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients. Psychopharmacology 101(3): 324-331, 1990

Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochemistry International 56(6-7): 774-779, 2010

CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. European Neuropsychopharmacology 17(1): 12-15, 2007

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. British Journal of Psychiatry 147: 276-282, 1985